Quijano, Mile Jhon .

HRN: 23-46-20  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/31/2023
CEFUROXIME 750MG (VIAL)
07/31/2023
08/07/2023
IVTT
250mg
Q8
PCAP.
Waiting Final Action 
07/31/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
07/31/2023
08/07/2023
IVT
65mg
Q8
Intestinal Infection
Waiting Final Action 
08/28/2023
CEFUROXIME 750MG (VIAL)
08/28/2023
09/03/2023
IV
250mg
Q8h
Intra-abdominal Infection
Waiting Final Action 
08/28/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
08/28/2023
09/03/2023
IV
70mg
Q8h
Intra-abdominal Infection
Waiting Final Action 
09/02/2023
CEFTRIAXONE 1G (VIAL)
09/02/2023
09/09/2023
IV
670mg
Q24h
Intraabdominal Infection
Waiting Final Action 
09/16/2023
CEFTRIAXONE 1G (VIAL)
09/16/2023
09/23/2023
IV
500 Mg
OD
PCAP
Waiting Final Action 
09/17/2023
AZITHROMYCIN 200MG/5ML, 15ML SUSPENSION (SUSP)
09/17/2023
09/19/2023
ORAL
1.5mL
OD
Pneumonia
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: